Benzinga | Oct 27, 2020 04:22PM EDT

Masimo: Q3 Earnings Insights

Shares of Masimo (NASDAQ:MASI) were unchanged after the company reported Q3 results.

Quarterly Results

Earnings per share rose 5.26% over the past year to $0.80, which beat the estimate of $0.62.

Revenue of $278,112,000 higher by 21.44% year over year, which beat the estimate of $256,580,000.

Looking Ahead

Masimo Sees FY20 Adj. EPS $3.46 vs $3.17 Estimate, Sales $1.128B vs $1.09B Est.

Details Of The Call

Date: Oct 27, 2020

Time: 04:30 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Finvestor.masimo.com%2F&eventid=2628642&sessionid=1&key=8CFB659E9AFC8455BD0D10B8496533BF&regTag=&sourcepage=register

Recent Stock Performance

Company's 52-week high was at $258.00

Company's 52-week low was at $140.53

Price action over last quarter: Up 14.66%

Company Description

Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (68% of 2019 sales), followed by Europe, the Middle East, and Africa (20%), Asia and Australia (9%), and North and South America excluding the U.S. (3%).